Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ANKRD11 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA565561
Description
Immunogen sequence: NKEKGQCSISQ ELKLKSFTYE YEDSKQKSDK AILLENDLST ENKLKVLKHD RDHFKKEEKL SKMKLEEKEW LFKDEKSLKR IKDTNKDISR SFR Highest antigen sequence identity to the following orthologs - mouse 84%, rat 79%.
ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
Specifications
ANKRD11 | |
Polyclonal | |
Unconjugated | |
ANKRD11 | |
2410104C19Rik; 3010027A04Rik; 6330578C09Rik; 9530048I21Rik; AA930108; ANCO1; ANCO-1; ANKRD11; ankyrin repeat domain 11; ankyrin repeat domain-containing protein 11; Ankyrin repeat-containing cofactor 1; fc59e05; fi04c06; Gm176; LOW QUALITY PROTEIN: ankyrin repeat domain-containing protein 11; LZ16; nasopharyngeal carcinoma susceptibility protein; T13; truncated ankyrin repeat domain 11 aberrant transcript 1; truncated ankyrin repeat domain 11 aberrant transcript 2; wu:fc59e05; wu:fi04c06; Yod | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
29123 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunocytochemistry | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q6UB99 | |
ANKRD11 | |
Recombinant Human ANKRD11. Recombinant protein control fragment (Product #RP-106235). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction